NCT06802536

Outcomes of Full Pulpotomy Treatment in Teeth With Symptoms of Irreversible Pulpitis

Treatment Outcomes of Full Pulpotomy Using Two Different Calcium Silicate-based Materials in Mature Permanent Teeth With Irreversible Pulpitis Symptoms: A Randomized Clinical Trial

• Status: Active Not Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Firat University · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

The aim of this clinical trial is to learn how successful Biodentine and NeoPutty dental filling materials are in treating dental pulp inflammation in adults. It will also provide information about post-treatment pain. The main questions it aims to answer are: Do Biodentine and NeoPutty dental filling materials treat dental pulpitis in participants? Do they reduce the need for root canal treatment? After the application of Biodentine and NeoPutty dental filling materials to the participants, the pain and symptoms that cause pain may not decrease. In this case, the tooth may be treated with root canal treatment. The researchers will compare the clinical success of Biodentine and NeoPutty dental filling materials with each other. Participants will undergo a single-session pulpotomy treatment with the dental filling materials mentioned above. Clinical and radiographic follow-ups will then be performed at 3, 6 and 12 months, and records will be kept.

Conditions

• Pulpitis - Irreversible

Interventions

Type	Name	Description
DEVICE	Biodentine (calcium silicate-based cement) (Septodont, Saint Maur de Fossés, France)	It will be placed on the exposed pulp with the help of a carrier and the exposed pulp will be covered with material.
DEVICE	NeoPutty (calcium silicate-based cement) (Avalon Biomed, Bradenton, USA)	It will be placed on the exposed pulp with the help of a carrier and the exposed pulp will be covered with material.

Timeline

• Start date: 2024-04-15
• Primary completion: 2025-12-26
• Completion: 2025-12-31
• First posted: 2025-01-31
• Last updated: 2025-09-23

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

• FDA-regulated device study